Skip to content

Attitudes on Marijuana and Psychedelics as a Treatment Option for Veterans

Peter Leasure, Jana Hrdinova, Douglas A. Berman, Dexter Ridgway

preprint DOI: 10.2139/ssrn.4655097 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational survey
Population Veterans, family members of veterans, and non-military individuals
Topics Cannabis
Key findings A sizeable majority of respondents supported marijuana as a treatment option and many supported psychedelics as a treatment option. Active-duty and veteran military personnel were somewhat less supportive of using historically illicit drugs as medical treatment than were family members and the general population.

Abstract

Many mental and physical health issues are prominent within the veteran community. Given the prevalence of health issues within the veteran community and the need for a wide range of treatment options, some researchers have started to explore whether and how veteran populations should have access to alternative treatment options such as marijuana and psychedelics. Additionally, some researchers have started to explore perceptions of alternative treatment options such as marijuana and psychedelics among military and veteran populations. Studies of veteran views on these issues, however, have not closely explored how veteran perspectives on certain drug issues compare directly to those in their immediate and broader community. Consequently, the current study sought to examine differences in attitudes towards marijuana and psychedelics as treatment options among veterans, family members of veterans, and non-military individuals. Our results indicated that a sizeable majority of respondents supported the use of marijuana as a treatment option, and that many respondents supported the use of psychedelics as a treatment option. That said, the results of this study also indicated that active and veteran military personnel remain somewhat less supportive in their viewpoints about use of historically illicit drugs as a medical treatment when compared to their family members and the general population.

Comparable studies

Other cross-sectional and survey studies on cannabis, most cited first.

Study Year Design Participants
Cannabis use before age 15 and subsequent executive functioning 104 chronic cannabis users (49 early-onset before age 15, 55 late-onset after age 15)... 2011 Observational cross-sectional study n = 148
Patterns of simultaneous polysubstance use in drug using university students Drug-using university students 2006 Cross-sectional survey n = 149
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Online survey respondents 2020 Cross-sectional survey
User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study Users of hallucinogenic drugs who completed a web-based questionnaire 2010 Cross-sectional survey n = 600
Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner Adults recruited from the MAPS website and newsletter, most reporting use of various... 2012 Cross-sectional survey n = 337

Explore topics